NMN for Biological Aging: What the Evidence Actually Shows
What is Biological Aging?
Biological aging refers to the gradual decline in cellular and organ function that accompanies chronological ageing. Key hallmarks include mitochondrial dysfunction, NAD+ decline, telomere shortening and cellular senescence.
NMN relevance: the published evidence
NAD+ falls with age and NMN raises NAD+ in human blood (Irie 2020, Igarashi 2022). Whether this translates to slower biological ageing in humans is unproven; epigenetic clock data are absent. Treat NMN as a hypothesis-driven longevity supplement, not a proven anti-ageing therapy.
Questions to ask before supplementing
250-500 mg/day used in published human trials.
Contraindications and red flags
No major contraindications at studied doses, but evidence of life-extension in humans does not exist.
Bottom line for Malaysian patients
NMN is not registered with NPRA as a treatment for any specific condition; it is sold as a general health supplement. If you have biological aging, use this page as a question list for a registered medical practitioner before adding NMN to existing therapy. Read our safety guide for full red-flag context.
Related conditions
- Age-Related Fatigue - Age-related fatigue is persistent low energy and reduced exercise tolerance that comes with ageing, ...
- Sarcopenia - Sarcopenia is the age-related loss of muscle mass, strength and function. It increases falls, disabi...
- Immunosenescence - Immunosenescence is the age-related decline of the immune system, marked by weaker vaccine responses...
- Telomere Shortening - Telomeres are protective DNA caps at chromosome ends that shorten with each cell division. Criticall...
Cited references
- Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men - Irie J 2020
- Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men - Igarashi M 2022
- NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR - Yoshino J 2018
- Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence - Rajman L 2018